Aurinia Pharmaceuticals Inc. (AUPH) SEC Filings — 2025
9 SEC filings for Aurinia Pharmaceuticals Inc. (AUPH) in 2025.
Filings
- Aurinia's Net Income Soars 16x on Strong LUPKYNIS Sales, Cost Cuts — 10-Q · Nov 4, 2025
- Aurinia's Q2 Revenue Jumps 30% Amidst Commercialization Push — 10-Q · Jul 31, 2025
- Aurinia Pharmaceuticals Files 8-K — 8-K · Jun 30, 2025
- Aurinia Pharmaceuticals Inc. Files 8-K on Corporate Governance Changes — 8-K · May 15, 2025
- Aurinia Pharmaceuticals Q1 2025 10-Q Filed — 10-Q · May 12, 2025
- Aurinia Pharmaceuticals Files Proxy Materials — DEFA14A · Apr 30, 2025
- Aurinia Pharmaceuticals Files Proxy Materials — DEFA14A · Apr 29, 2025
- Aurinia Pharma Files 2025 DEF 14A — DEF 14A · Apr 17, 2025
- Aurinia Pharmaceuticals Files 2024 10-K — 10-K · Feb 27, 2025